Introduction: Moyamoya disease is an uncommon cerebrovascular disease characterized by progressive steno-occlusive changes in terminal internal carotid arteries (ICAs) and their main branches, associated with development of moyamoya vessels.
INTRODUCTION
Moyamoya disease was first described in the Japanese literature in 1957 by Takeuchi and Shimizu as a case of "hypoplasia of the bilateral internal carotid arteries." 2 However, it was not until 1969 when Suzuki and Takaku 3 coined the term "moyamoya" signifying "something hazy, like a puff of cigarette smoke" to describe the angiographic appearance that would both describe and define the illness.
Moyamoya disease is a cerebrovascular arteriopathy of unknown origin characterized by progressive stenosis and, ultimately, occlusion of the distal intracranial ICAs and the proximal branches of the anterior and middle cerebral arteries. The resulting ischemia leads to the formation of multiple collaterals from the leptomeninges as well as both the external and intracranial ICAs. It is the dilated basal collateral vessels arising from the intracranial ICAs that lead to the characteristic angiographic appearance simulating a puff of smoke, termed as moyamoya. 4 The incidence of moyamoya disease is high in countries in East Asia, such as Japan and Korea. In Japan, the annual prevalence and incidence have been estimated to be 3.16 to 10.5 and 0.35 to 0.94 per 100,000 respectively. 5, 6 The annual incidences in the USA and Europe have been reported to be about 10% of that in Japan. 7 There is a bimodal age distribution of moyamoya disease, with the first peak occurring in the pediatric population, typically in the first decade of life, and a second peak between 30 and 40 years of age. 8 Moyamoya is found in both females and males; however, there is a clear female preponderance, with affected females outnumbering males nearly 2:1. 9 Familial occurrence is seen in 6 to 12% of cases. 4, 10, 11 Childhood moyamoya disease accounts for around 6% of cases of pediatric ischemic strokes and differs significantly from adult moyamoya disease. 12, 13 Firstly, in contrast to adults who often present within the setting of intracranial hemorrhage (<46%), 14 children affected with moyamoya disease typically exhibit signs and symptoms of cerebral ischemia secondary to TIAs and/or cerebral infarctions. Secondly, following a TIA, children have a much higher rate of completed infarcts when compared with their adult counterparts. This tendency is likely due to immature verbal skills in younger children making it difficult to communicate symptoms associated with TIAs, delaying the diagnosis of moyamoya and increasing likelihood of completed stroke upon presentation. 15 This signifies the importance of early diagnosis of childhood moyamoya disease.
MATERIALS AND METHODS
This is a cross-sectional observational study of 30 consecutive patients of moyamoya disease below 15 years of age, conducted at a tertiary care hospital in Eastern India between September 2010 and December 2014. All the patients underwent brain imaging in the form of computed tomography (CT), MRI, followed by cerebral angiography (MRA/ DSA) to confirm the diagnosis (Fig 1) . Diagnosis was made based on features of angiographic findings studied by the visualization of both the carotid and vertebrobasilar circulation. Secondary causes of moyamoya syndrome (prior radiotherapy to the head or neck for tumors, including craniopharyngiomas, pituitary tumors, optic gliomas; genetic disorders including Down's syndrome, neurofibromatosis type 1, tuberous sclerosis, sickle cell disease, and other hemoglobinopathies; autoimmune disorders including Grave's disease; vasculitis; congenital cardiac anomalies; renal artery stenosis; infections including tuberculous meningitis and leptospirosis; and fibromuscular dysplasia) were ruled out by relevant investigations. Enrolled patients were studied for demographic, clinical, and radiological profile.
RESULTS
Totally, 30 patients of childhood moyamoya disease were studied. Table 1 summarizes the demographic and clinical profile of the patients (n = 30).
Seven (23.33%) patients had presentations other than hemiparesis-headache in 1, headache + seizure in 1, recurrent TIA in 2, cognitive decline, bihemispherical TIA, and visual loss in 1 each. Table 2 summarizes the radiological profile of the patients (n = 30). Table 2 shows that ischemic stroke was the presentation in 22 (73.33%) patients and hemorrhagic stroke was the presentation in 1 (3.33%) patient. Seven (23.33%) patients had normal brain parenchyma, and the only diagnostic clue in these patients was the presence of abnormal flow voids; 1 patient presented with isolated infarct in the splenium of corpus callosum (Boomerang sign) 16 ( Fig. 2) .
Staging of the moyamoya disease in this study, as per the Suzuki staging system, 17 is depicted in Graph 1.
DISCUSSION

Demographic Profile
The clinicoradiological profile of moyamoya disease patients, especially in the pediatric age group, has been reported in a very few studies in literature. Initially it was believed that moyamoya disease was restricted to Japan, but later, cases were reported from all over the world, especially from China, Korea, and India. 7 The study done by Suzuki patients of moyamoya disease over a span of 3 years of which 11 were less than 15 years of age. Our study includes 30 patients of childhood moyamoya disease over a span of 4 years, the largest case series of childhood moyamoya disease in India, and the second largest case series of moyamoya disease overall. The reason for this large number of cases in our study is probably because our institute is the only tertiary care hospital catering to the entire Eastern and North-eastern India, as well as to the patients coming from the adjoining Bangladesh. Peak occurrence of childhood moyamoya disease as described in literature is in the age group of 5 to 9 years. 6 The mean age of patients in our study is 6.71 years with a range from 6 months to 15 years, with a maximum number of patients in the 5 to 10 years group (50%). This is in concordance with that reported in other studies. Mean age reported by Mugikura et al 18 was 6 ± 3 years 21 (all cases of childhood moyamoya disease) reported a male predominance with male-to-female ratio of 3.6:1. In our study, there was a slight female preponderance with a female-to-male ratio of 1.15:1.
Most patients with moyamoya disease are sporadic cases, but in Japan 10 to 15%, whereas in the United States, 6% of the cases have a family history of the disease. 4, 27, 28 Duan et al 26 reported 5.2% of cases to be familial, whereas Srivastava et al 23 had no familial cases similar to our study.
The female-to-male ratio in familial moyamoya disease is 5.0, which is much higher than that in sporadic cases (1.6).
The mean age at onset of familial moyamoya disease (11.8 years) is lower than that in sporadic cases (30.0 years).
29
Among parent-offspring pairs, the age at onset of offspring (7.2 years) is lower than that of parents (30.7 years), suggesting a strong association with anticipation in familial moyamoya disease. 29 The presence of familial cases in many reports across literature suggests that genetic factors participate in the etiology of moyamoya disease. 29 Associations with loci on chromosomes 3, 6, 8, and 17 (MYMY1, MYMY2, MYMY3) as well as specific human leukocyte antigen haplotypes have been described.
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Clinical Profile
The difference in presentation between children and adults with moyamoya disease is striking. It has been suggested that adults are less able to form collateral vessels than children. 36 The medial striate arteries in fetuses of children and adults were examined and it was found that with aging, there was a reduction in the number of anastomoses and in the caliber of vessels. The disease process in children is dynamic and progressive, while in adults, it appears static and arrested and this may be the basis for the clinical dichotomy. 17 In our study, ischemic stroke was the most common presentation seen in 73.33% of patients with hemiparesis as the most common presenting feature (63.33%); 23.33% of patients had presentation other than stroke, but their symptoms could be attributed to cerebral ischemia. So, a total of 96.66% patients had ischemic symptoms, whereas only 3.33% had hemorrhagic stroke as presentation. All patients in the studies conducted by Singhi et al 21 The only patient with hemorrhagic stroke presented with basal ganglia bleed with intraventricular hemorrhage. Duan et al 26 had 2.3% incidence of hemorrhagic stroke in the pediatric population, whereas Shoukat et al, 19 Srivastava et al 23 and Singhi et al 21 had none. Historically, bleeding has been attributed to rupture of fragile collateral vessels associated with moyamoya as progressive stenosis of the ICA occurs. 37, 38 Shifting circulatory patterns at the base of the brain have been implicated in the development of cerebral aneurysms (usually at the apex of the basilar artery and posterior communicating artery, areas of increased shear stress in moyamoya); this may be another cause of hemorrhage in moyamoya. 39, 40 Of the total patients, 23.33% had presentation other than stroke, which included TIAs and headache as presenting feature in 2 cases (6.66%) each, and seizures, cognitive decline, bihemispherical TIA, and visual loss as presentation in 1 case (3.33%), each as depicted in Table 1 . Headaches arise from hypoperfusion-induced activation of pain-sensitive structures, such as both intracranial and extracranial vasculature, dura, orbital contents, and mucous membranes of the oral and nasal cavities. 41 Concomitantly, other mechanisms, such as dilation of the meningeal collaterals stimulating dural nociceptors and ischemia-induced lowering of the migraine threshold have also been suggested. 8, 42 Disease bilaterality and duration of symptoms were the main factors associated with cognitive deficits, whereas age was not. 43 The role of a detrimental diffuse and prolonged ischemic-hypoxic mechanism in cognitive effects, similar to vascular cognitive impairment demonstrated in other brain hypoperfusion conditions in adults, has been suggested. 44 Our patient presenting with cognitive decline was found to have bilateral disease. Seizures, both focal and generalized, have been associated with moyamoya and are likely related to hypoperfusion. 45 Our patient presenting with visual loss was found to have occipital infarct. Other rare presentations reported in literature, but not found in our study, include choreiform movements 46 (attributed to any dysfunction of the basal ganglia-thalamocortical circuits, including infarctions IJPMR and mechanical compression by traversing dilated collateral vessels), 46 ,47 amourosis fugax, psychiatric manifestations, and subdural hemorrhage. 45 It is this group of patients presenting with features other than stroke, which require a strong suspicion of moyamoya disease so that an early diagnosis can be made and appropriate intervention initiated.
Radiological Profile
As discussed previously, 73.33% of patients presented with ischemic stroke. Out of this, anterior circulation stroke was present in 60%, posterior circulation stroke in 6.66%, whereas combined anterior and posterior circulation strokes were present in 6.66% cases; 1 patient presented with isolated infarct in the splenium of corpus callosum (Boomerang sign) (Fig. 2) . 16 Most common pattern of infarcts was combined cortical plus subcortical, followed by cortical, subcortical, and watershed infarcts; 7 patients (23.33%) had normal brain parenchyma on MRI. These patients were suspected to have moyamoya disease based on abnormal flow voids seen on MRI brain (on the background of a relevant history and neurological examination) (Fig. 1A) . These abnormal flow voids were in the form of either attenuation of the normal flow voids of middle cerebral artery/anterior cerebral artery/ICA or visualization of abnormal unusual flow voids at the base of brain, mainly around deep gray matter (Fig. 3A) . When they were subjected to angiography, the classical moyamoya pattern was found. Angiographically, posterior circulation is believed to be involved less frequently than anterior circulation. 48 Reason for this is that the pathology in moyamoya disease starts in the anterior circulation and then gradually spreads to involve posterior circulation in later stages; so, the posterior circulation acts as collateral pathway for the diseased anterior circulation till the later stage (Fig 4) . 48 In our study, bilateral ICA involvement with sparing of posterior circulation was the most common pattern found in 70% of our patients. Bilateral ICA with posterior circulation involvement was seen in 13.33%, unilateral ICA involvement in 16.66%, whereas isolated involvement of posterior circulation was not seen. Duan et al But this was in total contrast with our study, where almost all patients with posterior circulation involvement angiographically had posterior circulation infarcts. Bilateral involvement of ICA has been described as definite moyamoya disease whereas unilateral involvement of ICA has been described as probable moyamoya disease. 1 In our series, we had 16.66% cases with unilateral involvement. Duan et al 26 and Singhi et al 21 reported an incidence of 9.8 and 8.7% cases with unilateral moyamoya disease in their respective series.
There have been several reports of children presenting with unilateral moyamoya, and the obvious concern in these cases becomes contralateral progression of disease. The rate of progression of contralateral disease is variable. In the series of Smith and Scott, 8 56% children with unilateral disease developed contralateral stenosis over a 6-month to 4-year follow-up period, whereas in the series of Kelly et al, 49 38% went on to develop contralateral findings of moyamoya. It has been postulated that equivocal or mild stenosis in the contralateral hemisphere, congenital cardiac anomaly, Asian ancestry, and familial moyamoya syndrome were good predictors for the development of contralateral moyamoya. 49 Mean time to development of contralateral disease varies and has been reported as 12.7 months (5-22 months) to 3.1 years (0.5-7 years). 49, 50 In this series, 44% of children were diagnosed in stage 3 and 26% in stage 2 disease. This shows that most of the patients in our country are diagnosed when the disease has already evolved. This can be possibly due to inability of children to communicate their symptoms 15 as well as limited awareness of the myriad manifestations of moyamoya disease among the treating physicians, leading to a delayed diagnosis. None of the other studies have highlighted about the average stage of the disease at which the diagnosis was made.
CONCLUSION
To conclude, moyamoya disease is now a common disease entity and one should consider and rule out moyamoya disease in all patients with stroke, particularly in children.
Children can have a myriad of presentations, which are significantly different from the adult population. Though ischemic strokes are most common, hemorrhagic stroke may also occur. The various atypical presentations in this study included seizures, cognitive decline, headache, bihemispherical TIAs, visual loss, and presentation at an age as young as 6 months. Though anterior circulation involvement was commoner, posterior circulation involvement as well as unilateral cases were also seen. Most of the patients were in stage 2 and stage 3 at the time of diagnosis.
The neurological status at the time of treatment is more predictive of long-term outcome than age, and a delay in diagnosis can lead to permanent neurological and cognitive deficits. Also, surgical revascularization procedures can improve the prognosis in such patients significantly. Here lies the importance of early diagnosis of moyamoya disease which can be the key prognostic factor. Hence, physicians should be aware of the spectrum of presentations, of moyamoya disease especially the atypical ones, which can aid in early diagnosis, early intervention and improved outcome in our pediatric population.
